SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-γ and IL-4 signaling in vivo

被引:174
作者
Naka, T
Tsutsui, H
Fujimoto, M
Kawazoe, Y
Kohzaki, H
Morita, Y
Nakagawa, R
Narazaki, M
Adachi, K
Yoshimoto, T
Nakanishi, K
Kishimoto, T
机构
[1] Osaka Univ, Grad Sch Med, Dept Mol Med, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Microbiol, Suita, Osaka 5650871, Japan
[3] Hyogo Coll Med, Dept Immunol & Med Zool, Suita, Osaka 5650871, Japan
[4] Osaka Univ, Grad Sch, Suita, Osaka 5650871, Japan
关键词
D O I
10.1016/S1074-7613(01)00132-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Suppressor of cytokine signaling-1 (SOCS-1), also known as STAT-induced STAT inhibitor-1 (SSI-1), is a negative feedback molecule for cytokine signaling, and its in vivo deletion induces fulminant hepatitis. However, elimination of the STAT1 or STAT6 gene or deletion of NKT cells substantially prevented severe hepatitis in SOCS-1-deficient mice, while administration of IFN-gamma and IL-4 accelerated its development. SOCS-1 deficiency not only sustained IFN-gamma /lL-4 signaling but also eliminated the cross-inhibitory action of IFN-gamma on IL-4 signaling. These results suggest that SOCS-1 deficiency-induced persistent activation of STAT1 and STAT6, which would be inhibited by SOCS-1 under normal conditions, may induce abnormal activation of NKT cells, thus leading to lethal pathological changes in SOCS-1-deficient mice.
引用
收藏
页码:535 / 545
页数:11
相关论文
共 50 条
[41]   IL-4 INDUCES ALLERGIC-LIKE INFLAMMATORY DISEASE AND ALTERS T-CELL DEVELOPMENT IN TRANSGENIC MICE [J].
TEPPER, RI ;
LEVINSON, DA ;
STANGER, BZ ;
CAMPOSTORRES, J ;
ABBAS, AK ;
LEDER, P .
CELL, 1990, 62 (03) :457-467
[42]   A T-CELL-DEPENDENT EXPERIMENTAL LIVER-INJURY IN MICE INDUCIBLE BY CONCANAVALIN-A [J].
TIEGS, G ;
HENTSCHEL, J ;
WENDEL, A .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :196-203
[43]   SOCS-1,-2,-3: selective targets and functions downstream of the prolactin receptor [J].
Tomic, S ;
Chughtai, N ;
Ali, S .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 158 (1-2) :45-54
[44]  
Toyabe S, 1997, J IMMUNOL, V159, P1537
[45]   CHRONIC ACTIVE HEPATITIS IN TRANSGENIC MICE EXPRESSING INTERFERON-GAMMA IN THE LIVER [J].
TOYONAGA, T ;
HINO, O ;
SUGAI, S ;
WAKASUGI, S ;
ABE, K ;
SHICHIRI, M ;
YAMAMURA, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (02) :614-618
[46]  
TSUTSUI H, 1992, HEPATO-GASTROENTEROL, V39, P553
[47]  
Venkataraman C, 1999, J IMMUNOL, V162, P4053
[48]   The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop [J].
Yasukawa, H ;
Misawa, H ;
Sakamoto, H ;
Masuhara, M ;
Sasaki, A ;
Wakioka, T ;
Ohtsuka, S ;
Imaizumi, T ;
Matsuda, T ;
Ihle, JN ;
Yoshimura, A .
EMBO JOURNAL, 1999, 18 (05) :1309-1320
[49]   Negative regulation of cytokine signaling pathways [J].
Yasukawa, H ;
Sasaki, A ;
Yoshimura, A .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :143-164
[50]   Bone marrow and thymus expression of interferon-gamma results in severe B-cell lineage reduction, T-cell lineage alterations, and hematopoietic progenitor deficiencies [J].
Young, HA ;
Klinman, DM ;
Reynolds, DA ;
Grzegorzewski, KJ ;
Nii, A ;
Ward, JM ;
WinklerPickett, RT ;
Ortaldo, JR ;
Kenny, JJ ;
Komschlies, KL .
BLOOD, 1997, 89 (02) :583-595